Jaume Marrugat

Latest

• Women with Familial Hypercholesterolemia Phenotype are undertreated and poorly controlled compared to men
• Derivation and validation of SIDIAP-FHP score: A new risk model predicting cardiovascular disease in Familial Hypercholesterolemia
• Incidence of cardiovascular disease in patients with familial hypercholesterolemia phenotype: analysis of 5 years follow-up of real-world data from more than 1.5 million patients
• Three-year events and mortality in cardiovascular disease patients without lipid-lowering treatment
• Effectiveness of statins as primary prevention in people with gout: a population-based cohort study
• Number of patients eligible for PCSK9 inhibitors based on real-world data from 2.5 million patients
• Statins for primary prevention of cardiovascular events and mortality in the old and very old population: retrospective cohort study
• Association of classic cardiovascular risk factors and lifestyles with the cardio-ankle vascular index in a general Mediterranean population
• Effectiveness of statins as primary prevention in people with different cardiovascular risk: a population-based cohort study
• Differences in cardio-ankle vascular index in a general Mediterranean population depending on the presence or absence of metabolic cardiovascular risk factors
• Familial hypercholesterolemia in a european mediterranean population. Prevalence and clinical data from 2.5 million primary care patients
• Statins for prevention of cardiovascular events in a low-risk population with low ankle brachial index
• Prevalence of lower extremity peripheral arterial disease in individuals with chronic immune mediated inflammatory disorders
• Derivation and validation of BOREAS, a risk score identifying candidates to develop cold-induced hypertension
• Estimating the risk of peripheral artery disease using different population strategies